DOCSLIB.ORG

Association of the Gene Encoding the Δ-Subunit of the Muscle

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Association of the Gene Encoding the Δ-Subunit of the Muscle Genes and Immunity (2004) 5, 80–83 & 2004 Nature Publishing Group All rights reserved 1466-4879/04 $25.00 www.nature.com/gene BRIEF COMMUNICATION Association of the gene encoding the d-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis M Giraud1, B Eymard2, C Tranchant3, P Gajdos4 and H-J Garchon1 1INSERM U580, Hoˆpital Necker, Paris, France; 2Service de Neurologie, Institut de Myologie, Hoˆpital de la Salpeˆtrie`re, Paris; 3Service de Neurologie, Hoˆpital Civil, CHRU Strasbourg, France; 4Service de Re´animation, Hoˆpital Raymond Poincare´, Garches, France The muscle acetylcholine receptor (AChR) is the main target self-antigen in acquired autoimmune myasthenia gravis (MG). Here, we investigated an association of MG with the CHRND gene encoding the d-subunit of the AChR. Using a microsatellite repeat located in the second intron of the gene, we observed a preferential transmission of the allele 268 in 114 one-generation families with one myasthenic child (Pc ¼ 0.0154). This allele was also over-represented in a group of 350 unrelated nonthymoma MG patients (OR ¼ 1.78, P ¼ 0.038), but not in 84 thymoma patients, compared to 168 healthy controls. Moreover, among nonthymoma patients, those lacking serum anti-titin antibodies appeared to be best associated (OR ¼ 2.07, P ¼ 0.017). In contrast, there was no distortion in the transmission of a single-nucleotide substitution polymorphisms (SNPs) in the 30 untranslated region of CHRND nor in that of two SNPs located in the closely linked CHRNG gene, 4.5 kb telomeric to CHRND. The data warrant a detailed investigation of CHRND polymorphism in MG patients. Genes and Immunity (2004) 5, 80–83. doi:10.1038/sj.gene.6364041 Keywords: myasthenia gravis; genetics; CHRND; autoimmunity; acetylcholine receptor Acquired autoimmune myasthenia gravis (MG) is an pathogenesis.14,15 Finally, the importance of the d-subunit autoimmune disorder of the neuromuscular junction in muscle AChR structure and function was demon- resulting in fatigability of striated muscles.1–3 In most strated by the observation of congenital myasthenic patients, it is caused by autoantibodies directed at the syndromes that are caused by mutations in the CHRND muscle acetylcholine receptor (AChR), a pentameric gene.16,17 molecular complex made of four different subunits with The CHRND gene is located on chromosome 2q37.1 stoichiometry a2bde in adult or a2bgd in embryonic and consists of 12 exons spanning 9.3 kb (Figure 1). To muscle.4,5 As is the case for most autoimmune diseases, investigate an association with MG, we selected a (GA)n MG has a complex genetic control.6 An HLA-linked locus microsatellite repeat, CHRND_MS, located in its second has been characterized, but it explains the disease intron (The Genome Database: GDB:439020) and three susceptibility only partly.7 Given the central role of single nucleotide substitution polymorphisms (SNPs) AChR in MG pathogenesis, the genes that encode AChR that were described in dbSNP (build 96). Two of the subunits are candidates for an analysis of the genetic SNPs, rs1004432 and rs1550093, are in the last intron and factors that predispose to MG. On this basis, association the third one, rs2767, is in the 30 untranslated region. and linkage of CHRNA1, the gene for the a-subunit of Genotyping of the CHRND_MS microsatellite was the AChR, were demonstrated previously.8,9 conducted as described,18 except that one of the Here, we have investigated the role of the CHRND oligonucleotide primers that was used for amplification gene that encodes the d-subunit of the AChR. This gene was tagged with a fluorescent label. Amplification is also a candidate of great interest. The d-subunit products were migrated on an ABI 373XL automated displays immunogenic epitopes for both B and T sequencer (Applied Biosystems, Foster City, CA, USA). cells.10–12 It interacts with the a-subunit to form a Alleles were determined with the Genescan and Geno- heterodimer in the first step of AChR assembly in typer software and designated by their size in base pairs. muscle cells.13 In contrast, it is expressed at a very low SNPs were characterized by multiplexing single-base level in the thymus and it seems to be excluded from the chain extension reactions, using the SNaPshot system AChR complexes that are formed in this organ, which (Applied Biosystems). All markers were in Hardy– plays an essential role in tolerance induction and in MG Weinberg equilibrium. A transmission-disequilibrium test (TDT)19 was per- formed in 114 one-generation Caucasoid families with Correspondence: Dr HJ Garchon, INSERM U580, Hoˆpital Necker, 161 rue one child affected with MG. Transmission was assessed de Se`vres, 75743 Paris Cedex 15, France. E-mail: [email protected] as implemented in the Genehunter software.20 Cases Received 05 March 2003; revised 07 October 2003 with one missing parent were included only when the CHRND and myasthenia gravis M Giraud et al 81 Figure 1 Polymorphisms in the CHRND and CHRNG genes. Markers selected for the association study are shown by vertical bars. Transcriptional orientation of the genes is indicated by arrows. Open rectangles depict exons. Locus information and physical distances were obtained from the Ensembl web server (http://www.ensembl.org). Linkage disequilibrium between pairs of markers (square brackets) was estimated with the D0 measure, shown above the parentheses, using the expectation-maximization algorithm, as implemented in the LDMAX software (http://www.sph.umich.edu/csg/abecasis/GOLD/). genotyped parent and the proband were both distinct Table 1 Transmission of parental CHRND_MS microsatellite heterozygotes.21 For 64 patients, both parents could be alleles to MG offspring genotyped. For 50 other patients, one parent was available. Altogether, 98 parents were heterozygous for Allele Transmitted, N (%) Untransmitted, N (%) P-valuea CHRND_MS and 83 were informative for TDT. Hetero- zygous single parents exhibited CHRND_MS genotypes 258 4 (4.8) 4 (4.8) reflecting allele frequencies observed in the control 260 0 (0) 7 (8.4) ¼ ¼ 262 32 (38.6) 29 (34.9) population, including 260/262 (n 3), 262/264 (n 1), 264 3 (3.6) 5 (6.0) 262/266 (n ¼ 10), 262/268 (n ¼ 1), 258/266 (n ¼ 2), 264/ 266 26 (31.3) 33 (39.8) 266 (n ¼ 1) and 266/268 (n ¼ 4). As shown in Table 1, the 268 16 (19.3) 3 (3.6) 0.0154 CHRND_MS*268 allele was transmitted to 16 children 270 2 (2.4) 2 (2.4) and untransmitted in three cases (Pc ¼ 0.0154). In contrast, transmission of rs2767 alleles was balanced aExact probabilities were calculated using the binomial distribution. (17 transmitted vs 16 untransmitted), whereas rs1004432 They were corrected by multiplication by the number of alleles and rs155093 were not polymorphic in our population tested, including six alleles for the microsatellite (the allele 270 sample. Two-locus TDT disclosed a preferential trans- cannot yield significant results) and one allele for the rs2767 SNP. mission of the MS_268 allele combined to the ‘C’ allele of The only P-value o0.05 reported corresponded to a nominal P- rs2767, with a borderline significance (eight transmis- value of 0.0022. sions vs one nontransmission, corrected P ¼ 0.056 for four haplotypes tested). Altogether, the data demonstrated linkage of CHRND to MG, with a positive association of Table 2 CHRND_MS phenotype frequencies in thymoma and CHRND_MS*268. nonthymoma MG patients and in controls A case–control study comparing 444 unrelated Cauca- soid patients and 168 healthy control subjects was then Allele Nonthymoma Thymoma Controls performed (Table 2). The patient group included the 114 probands of the family-based analysis and 330 additional n ¼ 350 % n ¼ 84 % n ¼ 168 % unrelated patients. They were included in the study with their written informed consent and in keeping with the 258 14 4 6 7.1 3 1.8 tenets of the Declaration of Helsinki. They fulfilled 260 13 3.7 7 8.3 3 1.8 clinical and electromyographic diagnostic criteria of 262 274 78.3 75 89.3 136 81.0 acquired generalized MG. Moreover, as the CHRND 264 8 2.3 2 2.4 11 6.5 gene was a candidate, all the patients had confirmed 266 196 56 37 44 92 54.8 268 52 14.9a 8 9.5 15 8.9 positive titers of anti-AChR autoantibodies (40.6 nM), 270 7 2 2 2.4 4 2.4 determined with a radioimmunoprecipitation assay.22 In 282 patients who underwent thymectomy, histopathol- aOdds ratio for the comparison with controls: 1.78 (P ¼ 0.038). See ogy of the thymus was assessed as described elsewhere.7 details in Table 3. Patients with a thymoma were considered as a separate group. As a whole, they present a different clinical profile, often with severe clinical symptoms and they require specific treatments.1–3 In addition, in contrast to French blood donors recruited at the Necker Hospital nonthymoma patients, they showed no genetic associa- and 57 unrelated Caucasian French healthy individuals tion, whether at the HLA complex7 or at the CHRNA1 obtained from the Fondation Jean Dausset – CEPH locus (Giraud et al, submitted for publication). The (Centre d’Etudes du Polymorphisme Humain, Paris). control groups included 111 volunteering Caucasian Both groups showed very similar allele frequencies Genes and Immunity CHRND and myasthenia gravis M Giraud et al 82 Table 3 Odds ratios for CHRND_MS*268 in subgroups of nonthymoma MG patients compared to controls Patients N MS*268(+) % OR (95% CI) P-value Thymoma cases 84 8 9.5 1.07 All nonthymoma cases 350 52 14.9 1.78 (1.037 À +N) 0.038 TDT probands 94 17 18.1 2.24 (1.12 À +N) 0.026 Additional cases 256 35 13.7 1.61 Anti-titin antibody tested 294 44 15.0 1.79 (1.03 À +N) 0.04 Anti-titin positive 93 10 10.8 1.23 Anti-titin negative 201 34 16.9 2.07 (1.16 À +N) 0.017 aOdds ratios (OR), their 95% confidence interval (CI) and the P-values were calculated exactly with the Logxact software (Cytel corp, Cambridge, MA, USA).
Load more

Recommended publications
  • Research Article Microarray-Based Comparisons of Ion Channel Expression Patterns: Human Keratinocytes to Reprogrammed Hipscs To
    Hindawi Publishing Corporation Stem Cells International Volume 2013, Article ID 784629, 25 pages http://dx.doi.org/10.1155/2013/784629 Research Article Microarray-Based Comparisons of Ion Channel Expression Patterns: Human Keratinocytes to Reprogrammed hiPSCs to Differentiated Neuronal and Cardiac Progeny Leonhard Linta,1 Marianne Stockmann,1 Qiong Lin,2 André Lechel,3 Christian Proepper,1 Tobias M. Boeckers,1 Alexander Kleger,3 and Stefan Liebau1 1 InstituteforAnatomyCellBiology,UlmUniversity,Albert-EinsteinAllee11,89081Ulm,Germany 2 Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen, Pauwelstrasse 30, 52074 Aachen, Germany 3 Department of Internal Medicine I, Ulm University, Albert-Einstein Allee 11, 89081 Ulm, Germany Correspondence should be addressed to Alexander Kleger; [email protected] and Stefan Liebau; [email protected] Received 31 January 2013; Accepted 6 March 2013 Academic Editor: Michael Levin Copyright © 2013 Leonhard Linta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Ion channels are involved in a large variety of cellular processes including stem cell differentiation. Numerous families of ion channels are present in the organism which can be distinguished by means of, for example, ion selectivity, gating mechanism, composition, or cell biological function. To characterize the distinct expression of this group of ion channels we have compared the mRNA expression levels of ion channel genes between human keratinocyte-derived induced pluripotent stem cells (hiPSCs) and their somatic cell source, keratinocytes from plucked human hair. This comparison revealed that 26% of the analyzed probes showed an upregulation of ion channels in hiPSCs while just 6% were downregulated.
    [Show full text]
  • Cldn19 Clic2 Clmp Cln3
    NewbornDx™ Advanced Sequencing Evaluation When time to diagnosis matters, the NewbornDx™ Advanced Sequencing Evaluation from Athena Diagnostics delivers rapid, 5- to 7-day results on a targeted 1,722-genes. A2ML1 ALAD ATM CAV1 CLDN19 CTNS DOCK7 ETFB FOXC2 GLUL HOXC13 JAK3 AAAS ALAS2 ATP1A2 CBL CLIC2 CTRC DOCK8 ETFDH FOXE1 GLYCTK HOXD13 JUP AARS2 ALDH18A1 ATP1A3 CBS CLMP CTSA DOK7 ETHE1 FOXE3 GM2A HPD KANK1 AASS ALDH1A2 ATP2B3 CC2D2A CLN3 CTSD DOLK EVC FOXF1 GMPPA HPGD K ANSL1 ABAT ALDH3A2 ATP5A1 CCDC103 CLN5 CTSK DPAGT1 EVC2 FOXG1 GMPPB HPRT1 KAT6B ABCA12 ALDH4A1 ATP5E CCDC114 CLN6 CUBN DPM1 EXOC4 FOXH1 GNA11 HPSE2 KCNA2 ABCA3 ALDH5A1 ATP6AP2 CCDC151 CLN8 CUL4B DPM2 EXOSC3 FOXI1 GNAI3 HRAS KCNB1 ABCA4 ALDH7A1 ATP6V0A2 CCDC22 CLP1 CUL7 DPM3 EXPH5 FOXL2 GNAO1 HSD17B10 KCND2 ABCB11 ALDOA ATP6V1B1 CCDC39 CLPB CXCR4 DPP6 EYA1 FOXP1 GNAS HSD17B4 KCNE1 ABCB4 ALDOB ATP7A CCDC40 CLPP CYB5R3 DPYD EZH2 FOXP2 GNE HSD3B2 KCNE2 ABCB6 ALG1 ATP8A2 CCDC65 CNNM2 CYC1 DPYS F10 FOXP3 GNMT HSD3B7 KCNH2 ABCB7 ALG11 ATP8B1 CCDC78 CNTN1 CYP11B1 DRC1 F11 FOXRED1 GNPAT HSPD1 KCNH5 ABCC2 ALG12 ATPAF2 CCDC8 CNTNAP1 CYP11B2 DSC2 F13A1 FRAS1 GNPTAB HSPG2 KCNJ10 ABCC8 ALG13 ATR CCDC88C CNTNAP2 CYP17A1 DSG1 F13B FREM1 GNPTG HUWE1 KCNJ11 ABCC9 ALG14 ATRX CCND2 COA5 CYP1B1 DSP F2 FREM2 GNS HYDIN KCNJ13 ABCD3 ALG2 AUH CCNO COG1 CYP24A1 DST F5 FRMD7 GORAB HYLS1 KCNJ2 ABCD4 ALG3 B3GALNT2 CCS COG4 CYP26C1 DSTYK F7 FTCD GP1BA IBA57 KCNJ5 ABHD5 ALG6 B3GAT3 CCT5 COG5 CYP27A1 DTNA F8 FTO GP1BB ICK KCNJ8 ACAD8 ALG8 B3GLCT CD151 COG6 CYP27B1 DUOX2 F9 FUCA1 GP6 ICOS KCNK3 ACAD9 ALG9
    [Show full text]
  • Stem Cells and Ion Channels
    Stem Cells International Stem Cells and Ion Channels Guest Editors: Stefan Liebau, Alexander Kleger, Michael Levin, and Shan Ping Yu Stem Cells and Ion Channels Stem Cells International Stem Cells and Ion Channels Guest Editors: Stefan Liebau, Alexander Kleger, Michael Levin, and Shan Ping Yu Copyright © 2013 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “Stem Cells International.” All articles are open access articles distributed under the Creative Com- mons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Nadire N. Ali, UK Joseph Itskovitz-Eldor, Israel Pranela Rameshwar, USA Anthony Atala, USA Pavla Jendelova, Czech Republic Hannele T. Ruohola-Baker, USA Nissim Benvenisty, Israel Arne Jensen, Germany D. S. Sakaguchi, USA Kenneth Boheler, USA Sue Kimber, UK Paul R. Sanberg, USA Dominique Bonnet, UK Mark D. Kirk, USA Paul T. Sharpe, UK B. Bunnell, USA Gary E. Lyons, USA Ashok Shetty, USA Kevin D. Bunting, USA Athanasios Mantalaris, UK Igor Slukvin, USA Richard K. Burt, USA Pilar Martin-Duque, Spain Ann Steele, USA Gerald A. Colvin, USA EvaMezey,USA Alexander Storch, Germany Stephen Dalton, USA Karim Nayernia, UK Marc Turner, UK Leonard M. Eisenberg, USA K. Sue O’Shea, USA Su-Chun Zhang, USA Marina Emborg, USA J. Parent, USA Weian Zhao, USA Josef Fulka, Czech Republic Bruno Peault, USA Joel C. Glover, Norway Stefan Przyborski, UK Contents Stem Cells and Ion Channels, Stefan Liebau,
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence
    G C A T T A C G G C A T genes Article Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence Lingjun Zuo 1, Rolando Garcia-Milian 2, Xiaoyun Guo 1,3,4,*, Chunlong Zhong 5,*, Yunlong Tan 6, Zhiren Wang 6, Jijun Wang 3, Xiaoping Wang 7, Longli Kang 8, Lu Lu 9,10, Xiangning Chen 11,12, Chiang-Shan R. Li 1 and Xingguang Luo 1,6,* 1 Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA; [email protected] (L.Z.); [email protected] (C.-S.R.L.) 2 Curriculum & Research Support Department, Cushing/Whitney Medical Library, Yale University School of Medicine, New Haven, CT 06510, USA; [email protected] 3 Shanghai Mental Health Center, Shanghai 200030, China; [email protected] 4 Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT 06510, USA 5 Department of Neurosurgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China 6 Biological Psychiatry Research Center, Beijing Huilongguan Hospital, Beijing 100096, China; [email protected] (Y.T.); [email protected] (Z.W.) 7 Department of Neurology, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai 200080, China; [email protected] 8 Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Diseases of Tibet Autonomous Region, Xizang Minzu University School of Medicine, Xianyang, Shanxi 712082, China; [email protected] 9 Provincial Key Laboratory for Inflammation and Molecular Drug Target, Medical
    [Show full text]
  • Multiple Pterygium Syndrome
    Multiple pterygium syndrome Description Multiple pterygium syndrome is a condition that is evident before birth with webbing of the skin (pterygium) at the joints and a lack of muscle movement (akinesia) before birth. Akinesia frequently results in muscle weakness and joint deformities called contractures that restrict the movement of joints (arthrogryposis). As a result, multiple pterygium syndrome can lead to further problems with movement such as arms and legs that cannot fully extend. The two forms of multiple pterygium syndrome are differentiated by the severity of their symptoms. Multiple pterygium syndrome, Escobar type (sometimes referred to as Escobar syndrome) is the milder of the two types. Lethal multiple pterygium syndrome is fatal before birth or very soon after birth. In people with multiple pterygium syndrome, Escobar type, the webbing typically affects the skin of the neck, fingers, forearms, inner thighs, and backs of the knee. People with this type may also have arthrogryposis. A side-to-side curvature of the spine (scoliosis) is sometimes seen. Affected individuals may also have respiratory distress at birth due to underdeveloped lungs (lung hypoplasia). People with multiple pterygium syndrome, Escobar type usually have distinctive facial features including droopy eyelids (ptosis), outside corners of the eyes that point downward (downslanting palpebral fissures), skin folds covering the inner corner of the eyes (epicanthal folds), a small jaw, and low-set ears. Males with this condition can have undescended testes (cryptorchidism). This condition does not worsen after birth, and affected individuals typically do not have muscle weakness later in life. Lethal multiple pterygium syndrome has many of the same signs and symptoms as the Escobar type.
    [Show full text]
  • Med Chem Review
    1 CHAPTER 12 in Burger’s Medicinal Chemistry, Vol II Drug Discovery and Drug Development, Chapter 11, pp 357-405. Ed. Abraham, D., J. Wiley, New York., Nicotinic acetylcholine receptors David Colquhoun1, Nigel Unwin2, Chris Shelley1, Chris Hatton1 and Lucia Sivilotti3 1. Dept of Pharmacology, University College London, Gower Street, London WC1E 6BT 2. Neurobiology Division, MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK 3. Department of Pharmacology, The School of Pharmacy, 29/39, Brunswick Square, London WC1N 1AX. Corresponding author: D. Colquhoun ([email protected]) - 2 ABSTRACT Nicotinic receptors are cation-permeable ion channels activated by the neurotransmitter acetylcholine The muscle type receptor mediates all fast synaptic excitation on voluntary muscle. We review both the structure and the function of muscle/Torpedo receptor, and the function of several mutants. Recent developments in both knowledge of structure, and in analysis of single channel records, are beginning to throw light on the role of single amino acid residues in the molecular events (the binding of an agonist and the gating of the channel) that lead to channel opening. In the nervous system, nicotinic channels mediate the majority of fast excitation only in autonomic ganglia, but are also present at presynaptic locations. Issues of receptor classification and subunit composition are particularly relevant for neuronal channels, because of the numerous subunit combinations possible and because relatively few selective competitive antagonists are available, a situation that may improve with the characterisation of alpha-conotoxins. Inherited mutations in nicotinic channels gives rise to rare congenital forms of human disease (myasthenia for muscle and epilepsy for neuronal receptors).
    [Show full text]
  • ADX609 3301 Athena Newborndx Gene Panel Update 3-30-20.Indd
    NewbornDx™ Advanced Sequencing Evaluation When time to diagnosis matters, the NewbornDx™ Advanced Sequencing Evaluation from Athena Diagnostics delivers rapid, 3- to 7-day results on a targeted 1,722-genes. A2ML1 ALAD ATM CAV1 CLDN19 CTNS DOCK7 ETFB FOXC2 GLUL HOXC13 JAK3 AAAS ALAS2 ATP1A2 CBL CLIC2 CTRC DOCK8 ETFDH FOXE1 GLYCTK HOXD13 JUP AARS2 ALDH18A1 ATP1A3 CBS CLMP CTSA DOK7 ETHE1 FOXE3 GM2A HPD KANK1 AASS ALDH1A2 ATP2B3 CC2D2A CLN3 CTSD DOLK EVC FOXF1 GMPPA HPGD K ANSL1 ABAT ALDH3A2 ATP5A1 CCDC103 CLN5 CTSK DPAGT1 EVC2 FOXG1 GMPPB HPRT1 KAT6B ABCA12 ALDH4A1 ATP5E CCDC114 CLN6 CUBN DPM1 EXOC4 FOXH1 GNA11 HPSE2 KCNA2 ABCA3 ALDH5A1 ATP6AP2 CCDC151 CLN8 CUL4B DPM2 EXOSC3 FOXI1 GNAI3 HRAS KCNB1 ABCA4 ALDH7A1 ATP6V0A2 CCDC22 CLP1 CUL7 DPM3 EXPH5 FOXL2 GNAO1 HSD17B10 KCND2 ABCB11 ALDOA ATP6V1B1 CCDC39 CLPB CXCR4 DPP6 EYA1 FOXP1 GNAS HSD17B4 KCNE1 ABCB4 ALDOB ATP7A CCDC40 CLPP CYB5R3 DPYD EZH2 FOXP2 GNE HSD3B2 KCNE2 ABCB6 ALG1 ATP8A2 CCDC65 CNNM2 CYC1 DPYS F10 FOXP3 GNMT HSD3B7 KCNH2 ABCB7 ALG11 ATP8B1 CCDC78 CNTN1 CYP11B1 DRC1 F11 FOXRED1 GNPAT HSPD1 KCNH5 ABCC2 ALG12 ATPAF2 CCDC8 CNTNAP1 CYP11B2 DSC2 F13A1 FRAS1 GNPTAB HSPG2 KCNJ10 ABCC8 ALG13 ATR CCDC88C CNTNAP2 CYP17A1 DSG1 F13B FREM1 GNPTG HUWE1 KCNJ11 ABCC9 ALG14 ATRX CCND2 COA5 CYP1B1 DSP F2 FREM2 GNS HYDIN KCNJ13 ABCD3 ALG2 AUH CCNO COG1 CYP24A1 DST F5 FRMD7 GORAB HYLS1 KCNJ2 ABCD4 ALG3 B3GALNT2 CCS COG4 CYP26C1 DSTYK F7 FTCD GP1BA IBA57 KCNJ5 ABHD5 ALG6 B3GAT3 CCT5 COG5 CYP27A1 DTNA F8 FTO GP1BB ICK KCNJ8 ACAD8 ALG8 B3GLCT CD151 COG6 CYP27B1 DUOX2 F9 FUCA1 GP6 ICOS KCNK3 ACAD9 ALG9
    [Show full text]
  • ION CHANNEL RECEPTORS TÁMOP-4.1.2-08/1/A-2009-0011 Ion Channel Receptors
    Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Tímea Berki and Ferenc Boldizsár Signal transduction ION CHANNEL RECEPTORS TÁMOP-4.1.2-08/1/A-2009-0011 Ion channel receptors 1 Cys-loop receptors: pentameric structure, 4 transmembrane (TM) regions/subunit – Acetylcholin (Ach) Nicotinic R – Na+ channel - – GABAA, GABAC, Glycine – Cl channels (inhibitory role in CNS) 2 Glutamate-activated cationic channels: (excitatory role in CNS), tetrameric stucture, 3 TM regions/subunit – eg. iGlu 3 ATP-gated channels: 3 homologous subunits, 2 TM regions/subunit – eg. P2X purinoreceptor TÁMOP-4.1.2-08/1/A-2009-0011 Cys-loop ion-channel receptors N Pore C C C N N N N C C TM TM TM TM 1 2 3 4 Receptor type GABAA GABAC Glycine g a b p2 p1 b a Subunit diversity a1-6, b1-3, g1-3, d,e,k, and q p1-3 a1-4, b TÁMOP-4.1.2-08/1/A-2009-0011 Vertebrate anionic Cys-loop receptors Type Class Protein name Gene Previous names a1 GABRA1 a2 GABRA2 a3 GABRA3 EJM, ECA4 alpha a4 GABRA4 a5 GABRA5 a6 GABRA6 b1 GABRB1 beta b2 GABRB2 ECA5 b3 GABRB3 g1 GABRG1 GABAA gamma g2 GABRG2 CAE2, ECA2, GEFSP3 g3 GABRG3 delta d GABRD epsilon e GABRE pi p GABRP
    [Show full text]
  • Ion Channels in the P14 Rat Brain
    A Digital Atlas of Ion Channel Expression Patterns in the Two-Week-Old Rat Brain Volodymyr Shcherbatyy1, James Carson2, Murat Yaylaoglu1, Katharina Jäckle1, Frauke Grabbe1, Maren Brockmeyer 1, Halenur Yavuz 1, and Gregor Eichele1* 1 Department of Genes and Behavior, Max Plank Institute for Biophysical Chemistry, Göttingen, Germany 2 Life Sciences Computing, Texas Advanced Computing Center, Austin, TX, USA * Correspondence to: Gregor Eichele, Department of Genes and Behavior, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077 Göttingen, Germany E-mail address: [email protected] Online Resource 1 ESM_1. List of ion channels examined in the P14 rat brain. ISH data are viewable using the entry interface of Genepaint.org (http://www.genepaint.org/) by entering the gene symbol or Genepaint set ID (a database internal ID). In the Genepaint.org database, images of individual sections can be viewed at full resolution by using the virtual microscope tools. Additionally, the full template sequence, specimen properties, gene accession number and Entrez Gene ID can be retrieved and images can be downloaded as described in the Manual of Genepaint under “Zoom Viewer” on the Genepaint.org home page [see also (Geffers et al. 2012)]. Supplemental references Geffers, L., Herrmann, B., & Eichele, G. (2012). Web-based digital gene expression atlases for the mouse. Mamm Genome, 23(9-10), 525-538, doi:10.1007/s00335-012-9413-3. Page 1 of 16 ESM_1. List of ion channels examined in the P14 rat brain qPCR Analysis Rat Gene Genepaint
    [Show full text]
  • Identification of Differentially Expressed Genes in Pathways of Cerebral Neurotransmission of Anovulatory Mice
    Identification of differentially expressed genes in pathways of cerebral neurotransmission of anovulatory mice M.A. Azevedo Jr. and I.D.C.G. Silva Laboratório de Ginecologia Molecular, Universidade Federal de São Paulo, São Paulo, SP, Brasil Corresponding authors: M.A. Azevedo Jr. / I.D.C.G. Silva E-mail: [email protected] / [email protected] Genet. Mol. Res. 16 (3): gmr16039622 Received January 18, 2017 Accepted September 4, 2017 Published September 27, 2017 DOI http://dx.doi.org/10.4238/gmr16039622 Copyright © 2017 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution ShareAlike (CC BY-SA) 4.0 License. ABSTRACT. Polycystic ovary syndrome is the classic example of loss of functional cyclicity and anomalous feedback. In this case, the excessive extra-glandular production and conversion of androgens to estrogens are the pathophysiological basis of the chronic anovulation. The literature describes an experimental model of the polymicrocystic ovary in obese diabetic mice with insulin resistance. The fact that these animals exhibit obesity, insulin resistance, and infertility demonstrates their skill as an experimental model for polycystic ovary. A recent study using long protocol for up to 40 weeks showed that anovulatory and obese mice transplanted with adipose tissue from animals with normal weight have multiple changes in their phenotype. These changes include reduction of body weight, prevention of obesity, insulin level normalization, and insulin tolerance tests, preventing the elevation of steroids and especially the reversal of fertility restoration with anovulation. Considering that there are close relationships between the ovulation process and the central nervous system, we propose to evaluate the gene expression levels of 84 different genes involved in neurotransmission and insulin pathways in addition to examining the Genetics and Molecular Research 16 (3): gmr16039622 M.A.
    [Show full text]
  • Transcriptional Landscapes of Emerging Autoimmunity
    Emergence of Autoimmunity in C57BL/6.NOD-Aec1Aec2 mice p r e a - u t t o o i s m t u i m m b u c e l n i l n i i t n i y c e a l f r o m s u b 4 c l s t i o n t a i c b 1 a l 6 l e p w h e a s e e k s S s u o j ö b f g c a r l e in g n i e c ’ s a l s t y o n d o r v o e m r t e transcriptional landscape of salivary glands targeted by autoimmunity innate immunity (darkened = dependence on susceptibility regions) adaptive immunity (darkened = dependence on susceptibility regions) Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue’s extracellular milieu precede immune responses in Sjögren’s syndrome Delaleu et al. Delaleu et al. Arthritis Research & Therapy 2013, 15:R174 http://arthritis-research.com/content/15/5/R174 Delaleu et al. Arthritis Research & Therapy 2013, 15:R174 http://arthritis-research.com/content/15/5/R174 RESEARCH ARTICLE Open Access Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue’s extracellular milieu precede immune responses in Sjögren’s syndrome Nicolas Delaleu1*, Cuong Q Nguyen2, Kidane M Tekle3, Roland Jonsson1,4 and Ammon B Peck2 Abstract Introduction: Our understanding of autoimmunity is skewed considerably towards the late stages of overt disease and chronic inflammation. Defining the targeted organ’s role during emergence of autoimmune diseases is, however, critical in order to define their etiology, early and covert disease phases and delineate their molecular basis.
    [Show full text]